Diabetes Relevance For type 2 diabetes, CagriSema has an intuitive path because one component is semaglutide, an established GLP-1 therapy, and the amylin component may improve appetite and post-prandial glucose handling
Hepatogastroenterology 1999
GLP-1 foods like whole grains, vegetables, beans, peas, lentils, fruits, nuts, and seeds help meet daily fibre needs and lower the risk of constipation
Currently, the most popular GLP1-based monotherapy, Semaglutide, controls blood sugar by promoting insulin secretion and induces a lasting sense of fullness to reduce appetite
The appetite suppression gives them a "quieter" food environment so that their existing discipline translates efficiently into a sustained calorie deficit
BMJ Open 13 , e063026 (2023)